While we did not detect any links to primary disease-related outcomes in the fasting-induced gut microbiome changes in patients with T1D (such as insulin dose or glucose levels), we did detect that changes in certain microbiota members correlated with cardiometabolic risk markers (blood pressure and cholesterol levels). Here, INS is linked to type 1 diabetes mellitus.